Historical Stock Price
PLX historical stock prices picture
Protalix BioTherapeutics (PLX) has the following price history information. Looking back at PLX historical stock prices for the last five trading days, on March 21, 2024, PLX opened at $1.37, traded as high as $1.37 and as low as $1.30, and closed at $1.32. Trading volume was a total of 294.70K shares. On March 22, 2024, PLX opened at $1.32, traded as high as $1.32 and as low as $1.26, and closed at $1.27. Trading volume was a total of 249.20K shares. On March 25, 2024, PLX opened at $1.27, traded as high as $1.31 and as low as $1.21, and closed at $1.22. Trading volume was a total of 707.50K shares. On March 26, 2024, PLX opened at $1.23, traded as high as $1.25 and as low as $1.22, and closed at $1.22. Trading volume was a total of 366.10K shares. On March 27, 2024, PLX opened at $1.22, traded as high as $1.28 and as low as $1.22, and closed at $1.25. Trading volume was a total of 378.20K shares.

PLX Historical Stock Prices By Date:

PLX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Protalix BioTherapeutics shares, starting with a $10,000 purchase of PLX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 03/27/2024
Start price/share: $45.80
End price/share: $1.25
Dividends collected/share: $0.00
Total return: -97.27%
Average Annual Total Return: -30.25%
Starting investment: $10,000.00
Ending investment: $272.82
Years: 10.00
Date Open High Low Close Volume
03/21/2024 $1.37 $1.37 $1.30 $1.32 294.70K
03/22/2024 $1.32 $1.32 $1.26 $1.27 249.20K
03/25/2024 $1.27 $1.31 $1.21 $1.22 707.50K
03/26/2024 $1.23 $1.25 $1.22 $1.22 366.10K
03/27/2024 $1.22 $1.28 $1.22 $1.25 378.20K
Protalix BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Co.'s proprietary ProCellEx platform is being used to manufacture its marketed product, Elelyso®, for the treatment of Gaucher disease. Co. is also developing, via ProCellEx, a pipeline of products. Co.'s clinical development program for pegunigalsidase alfa, or PRX-102, for the potential treatment of Fabry disease. In addition, Co. is developing uricase, or PRX-115, for the treatment of refractory gout.
Date Close
03/21/2024$1.32
03/22/2024$1.27
03/25/2024$1.22
03/26/2024$1.22
03/27/2024$1.25
PLX is categorized under the Healthcare sector; below are some other companies in the same sector:

PLXP Historical Stock Prices
PMC Historical Stock Prices
PMD Historical Stock Prices
PODD Historical Stock Prices
POZN Historical Stock Prices
PPHM Historical Stock Prices
PRAH Historical Stock Prices
PRAN Historical Stock Prices
PRGO Historical Stock Prices
PRPH Historical Stock Prices

Email EnvelopeFree PLX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


PLX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.